Table 1. Motor and non-motor symptoms in PD - descriptive data.
| Mean/Frequency | Standard Deviation/percentage | Range | |
|---|---|---|---|
| Age | 73.3 | 8.8 | 42–94 |
| Gender (male) | 70 | 49 | |
| Age of onset | 65.9 | 11.1 | 28–92 |
| Duration of symptoms | 7.6 | 6.3 | 1–38 |
| LED | 538.4 | 382.2 | 0.0–1600.0 |
| Hohen and Yahr stage | 2.4 | 0.9 | 0–5 |
| UPDRS III Total | 28.2 | 16.8 | 0–104 |
| UPDRS III Dysarthria | 1.13 | 1.0 | 0–4 |
| UPDRS III Tremor | 4.5 | 3.6 | 0–19 |
| UPDRS III Rigidity | 4.1 | 4.0 | 0–15 |
| UPDRS III Bradykinesia | 11.8 | 7.9 | 0–36 |
| UPDRS III Gait/Posture | 2.5 | 1.8 | 0–8 |
| MoCA | 18.5 | 6.8 | 0–30 |
| RBDSQ | 6.32 | 3.4 | 1–13 |
| HADS - Anxiety | 8.0 | 4.4 | 0–20 |
| HADS - Depression | 8.3 | 5.2 | 0–24 |
| SCOPA-Sleep Daytime | 3.4 | 4.8 | 0–36 |
| SCOPA-Sleep Nighttime | 4.4 | 3.9 | 0–15 |
| PPQ | 3.8 | 3.2 | 0–14 |
| Apathy | 11.9 | 7.7 | 0–43 |
| NMSS total | 60.9 | 45.8 | 2–190 |
| NMSS Affection/Cognition | 16.4 | 17.0 | 0–72 |
| NMSS Perception/Hallucinations | 2.0 | 4.6 | 0–24 |
| NMSS Sleep/Fatigue | 10.0 | 8.0 | 0–34 |
| NMSS Cardiovascular | 1.5 | 0.5 | 1–2 |
| NMSS Attention/Memory Complaints | 8.0 | 9.0 | 0–36 |
| NMSS Gastrointestinal | 4.9 | 6.4 | 0–30 |
| NMSS Urinary | 7.5 | 9.1 | 0–36 |
| NMSS Sexual Function | 3.6 | 6.4 | 0–24 |
| NMSS Pain | 1.5 | 3.0 | 0–12 |
| NMSS Olfaction | 2.9 | 4.4 | 0–16 |
| NMSS Weight Change | 1.1 | 2.7 | 0–12 |
| NMSS Hyperhidrosis | 1.6 | 3.9 | 0–24 |
| NMSS Euro-QoL Index | 0.3 | 0.3 | −0.6–0.7 |
| NMSS EQ-VAS | 62.0 | 21.2 | 0–100 |
| UPDRS II | 13.9 | 9.7 | 0–52 |
| Schwab and England Activities of Daily Living (ADL) | 75.5 | 19.2 | 10–100 |
UPDRS - Unified Parkinson’s Disease Rating Scale; NMSS - Non-Motor Symptom Scale; MoCA - Montreal Cognitive Assessment scale; RBDSQ - REM Sleep Behavioral Disorder Symptom Questionnaire; HADS - Hospital Anxiety and Depression Scale, SCOPA - Scale for Outcomes in Parkinson’s Disease; PPQ - Parkinson’s Psychosis Questionnaire.